Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Control of Iatrogenic Endobronchial Bleeding by Tranexamic Acid，Adrenalin and Hemagglutinase: a Double-blind Randomized Controlled Trial

NCT06149091 is registered in ClinicalTrials.gov with China-Japan Friendship Hospital as lead sponsor.

NCT NCT06149091
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06149091 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Control of Iatrogenic Endobronchial Bleeding by Tranexamic Acid，Adrenalin and Hemagglutinase: a Double-blind Randomized Controlled Trial
Lead sponsor
China-Japan Friendship Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
December 1, 2023
Completion date
December 31, 2024
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

iatrogenic endobronchial bleeding